Inhibiting peptidases can have significant implications in toxicology. Peptidase inhibitors are often used in research and medicine to regulate enzyme activity, which can be beneficial in treating diseases but may also lead to unintended side effects. Inhibition of peptidases can disrupt normal metabolic pathways, potentially leading to the accumulation of toxic intermediates. Therefore, careful consideration and thorough research are necessary when developing or using peptidase inhibitors.
